Neurovascular intervention is referred to prevention, diagnosis, treatment and rehabilitation of vascular disorders of the central nervous system with minimal invasive procedures or technologies. Neurovascular disorders are normally treated through micro catheters or by emolization or recanalization of the abnormal vessels.
One of the major factors contributing to the growth of this market is the huge patient pool suffering from various neurological disorders. Other major factors driving the market for neurovascular intervention devices include advancement in device and treatment technology, high incidences of ischemic and hemorrhagic strokes, increasing demand for surgical procedures with minimal invasion, market consolidation and innovative initiatives taken up by leading market players. However, major challenge to the growth of this market is high cost involved in neurovascular intervention treatment.
Geographically, the market is segmented into Asia Pacific, North America, Europe, and Rest of the World. Presently, North America holds a lion’s share in the global neurovascular intervention market, with Europe following its lead. The ever-increasing pool of geriatrics in these regions and the high rate of obesity have both contributed to the growth of the market in these regions. On the other hand, researchers estimate that emerging economies of Japan, China, and India in Asia Pacific along with countries such as Chile, Argentina, and Brazil in Latin America will also lend an impetus to the market due to the improving purchasing power of consumers.
Obtain the Future Market Projections for Neurovascular Intervention at: http://bit.ly/2gj4PFl
Some of the key players operating in the global neurovascular intervention market are Johnson & Johnson, Cardiatis, S.A., Abbott Laboratories, Flexible Stenting Solutions, Inc., Boston Scientific Corporation, Bayer AG, Chestnut Medical Technologies, Inc., Covidien PLC, ITGI Medical Ltd., Phenox GmbH, Penumbra, Inc., Stryker Corporation, Sequent Medical, Inc., Terumo Corporation, and NeuroVasx, Inc. The research report provides a granular view of the competitive landscape present in the global market and estimates the bargaining power of suppliers and buyers. Additionally, it also provides an understanding of the threat of new entrants to the existing players. The researchers have also dedicated a chapter to explaining the business and marketing strategies likely to be used by neurovascular intervention market in the coming few years to strengthen their position in the global market.
Neurovascular intervention market is segmented on following basis:
> Endovascular cerebral aneurysm
> Acute ischemic stroke
> Chronic ischemic stroke
> Intracranial atherosclerotic disease
> Neurovascular embolic coils
> DNeurovascular liquid embolism
> Intracranial stents & flow diverting devices
> Neurovascular thrombectomy devices
> Carotid stents & embolic protection devices
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.